- €1.01bn
- €1.22bn
- €856.33m
- 85
- 41
- 79
- 81
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 287 | 402 | 430 | 546 | 856 |
Cost of Revenue | |||||
Gross Profit | 248 | 354 | 382 | 487 | 780 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 269 | 360 | 386 | 500 | 744 |
Operating Profit | 18.6 | 42.4 | 44.5 | 45.7 | 112 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 14.4 | 37.2 | 37.7 | 38.2 | 102 |
Provision for Income Taxes | |||||
Net Income After Taxes | 8.17 | 30.4 | 24.4 | 30 | 77.3 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 6.85 | 25.5 | 18.4 | 30 | 77.3 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 6.85 | 25.5 | 18.4 | 25.9 | 77.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.612 | 2.21 | 1.61 | 2.37 | 5.6 |
Dividends per Share |